<collection><source>PMC</source><date>20201214</date><key>pmc.key</key><document><id>29014</id><infon key="license">NO-CC CODE</infon><passage><infon key="article-id_pmc">29014</infon><infon key="article-id_pmid">11056724</infon><infon key="article-id_publisher-id">cc-3-1-051</infon><infon key="fpage">51</infon><infon key="issue">1</infon><infon key="journal-title">Critical Care</infon><infon key="kwd">catheter drugs pediatrics</infon><infon key="lpage">53</infon><infon key="name_0">surname:Reyes;given-names:Gerardo</infon><infon key="name_1">surname:Mander;given-names:Gurpreet S</infon><infon key="name_2">surname:Husayni;given-names:Tarek S</infon><infon key="name_3">surname:Sulayman;given-names:Rabi F</infon><infon key="name_4">surname:Jaimovich;given-names:David G</infon><infon key="section_type">TITLE</infon><infon key="type">front</infon><infon key="volume">3</infon><infon key="year">1999</infon><offset>0</offset><text>In-vivo evaluation of simultaneous administration of incompatible 		  drugs in a central venous catheter with a decreased port to port distance</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>144</offset><text>What is the backstory?</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>156</offset><text>Critically ill children often use multilumen catheters, but their use is associated with high morbidity. We investigated the use of a new triple-lument catheter with reduced length and greater port to port distance while administering incompatible drugs.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>446</offset><text>Techniques:</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>455</offset><text>The distal port was used to provide total parenteral nutrition to ten 10-20 kg domestic swine, while each group received phenytoin as a bolus and infusion. Histograms were produced for particle size and concentration, and samples were examined under the microscope for particles.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>931</offset><text>What are the results?</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>940</offset><text>The study or control samples did not display any variation in particle size based on histograms, and no particles were detected using phase microscope, light microscope (PhS) or Wright stain smear.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>1202</offset><text>Remarks:</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>1215</offset><text>The use of a triple-lumen catheter with 0.4cm of space between the proximal port and the medial port, and 1.3 cm of distance between them and their distal port in order to administer incompatible solutions does not lead to adverse clinical effects.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>1543</offset><text>Introduction</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>1556</offset><text>In the 1970s, a technique was developed for the simultaneous administration of incompatible drugs across a central venous catheter with a decreased port to port distance. The drug is then placed in the catheter and the port is closed. After several hours, the drug is removed from the catheter and the port closed. The drug is then placed in a separate container and the port open.

The drug is then placed in a separate container and the port open. The drug is then placed in a separate container and the port closed. The drug is then placed in a separate container and the port closed. The drug is then placed in a separate container and the port closed. The drug is then placed in a separate container and the port closed. The drug</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>2327</offset><text>The study examined a triple-lumen catheter with alterations in its design, measuring 5.5 F  5 cm (Arrow International), with an additional 0.4 cm port distance between the medial and proximal ports and only 1.3 cm from the distal or lateral ports, and having fewer port spaces between lumens to determine if they precipitate when given intravenous solutions that are not incompatible at the same time.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_1</infon><offset>2779</offset><text>Materials and methods</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>2801</offset><text>Ten domestic swine weighing 10&#8211;20 kg were anesthetized with ketamine 10 mg/kg intramuscularly, atropine 0.01 mg/kg intravenously, and isoflurane for 		  continuous anesthesia. The trachea was intubated with a #5 or #6 uncuffed 		  endotracheal tube and controlled ventilation was instituted to maintain normal 		  blood gases. A lead II electrocardiogram was monitored continuously along with 		  temperature, respiration, and blood pressure. A peripheral vein was isolated 		  and cannulated for fluid and anesthetic administration as necessary during the 		  experiment. The femoral veins in both hind limbs were isolated by the cut-down 		  technique. The experimental triple-lumen catheter, with decreased port to port 		  distances, was inserted into the right femoral vein, and the control catheter 		  was inserted into the left femoral vein under direct visualization. The control 		  catheter was a 5.5 F &#215; 5 cm, triple-lumen catheter with a standard port 		  distance of 1.6cm between the proximal and medial ports and 1.6 cm between the 		  medial and distal ports respectively, for a total distance of 3.2 cm between the 		  distal port and the proximal port (Arrow International). The size of the lumens 		  is 20 gauge for the distal lumen, and 22 gauge for the medial and proximal 		  lumens. Placement was confirmed by aspiration of blood from all ports.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>4175</offset><text>A midline incision was made, the peritoneum was identified, and the 		  incision was extended to isolate and retract peritoneal contents exposing the 		  retroperitoneal vasculature. The iliac vessels and the inferior vena cava were 		  dissected and isolated. Sampling sites were identified immediately distal to 		  the catheter tip and one catheter length distal to the first sampling site. An 		  18-gauge catheter with a three-way stop-cock was inserted at each sampling site 		  (Fig 1). Hematocrit was between 35% and 45% during the 		  experiment.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>4731</offset><text>Phenytoin and total parenteral nutrition (TPN) were shown to be 		  incompatible in vitro in a previous study. A 		  solution of phenytoin with a concentration of 50 mg/ml and pH12 as evaluated on 		  a pH meter (255 Ph/ISE, CIBA Corning Diagnostics, Oberlin, Ohio, USA) was 		  administered to all animals (n = 10) through the distal lumen at the 		  usual maintenance dose of 2.5 mg/kg/dose at a rate of 1 mg/kg/min up to a 		  maximum of 50 mg/min via a syringe infusion pump (1001, Medfusion Systems, 		  Norcross, Georgia, USA). The bolus was followed by a 3 ml normal saline flush. 		  The TPN solution (Table 1), with a pH of 5.8, was 		  administered simultaneously through the medial lumen at the standard clinical 		  maintenance rate calculated in ml/kg/day and divided over a 24-h period using 		  the same syringe infusion pump system. In the second phase of the experiment, 		  the same procedure described above was performed with the phenytoin solution 		  administered through the medial lumen and the TPN administered through the 		  distal lumen. In the final phase, the phenytoin was administered through the 		  proximal lumen and the TPN through the medial lumen. The same methodology was 		  repeated on the opposite limb using the control catheter.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>6004</offset><text>Blood sampling was performed mid-way through the phenytoin bolus 		  administration, and at 1, 5, 10, and 15 min intervals for all ports of both 		  catheters. Sampling was performed simultaneously at both sampling sites; each 		  sample consisted of 1 ml whole blood. Histograms were generated by a coulter 		  counter (Sysmex K-1000, Long Grove, Illinois, USA) for particle size. Quality 		  control on the analyzer is performed on a real-time basis using commercial 		  controls once every 8-h shift on a daily basis (Equinox 16T, Hematronix Inc., 		  Benicia, California,USA). All quality control data are handled according to 		  current College of American Pathologists' standards. Calibration of the 		  analyzer is checked quarterly using a commercial calibrator. Blinded specimens 		  were examined microscopically by phase microscope, light microscope, and Wright 		  stain smears.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>6896</offset><text>The experimental protocol was reviewed and approved by the animal care 		  committee of our institution.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_1</infon><offset>7001</offset><text>Results</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>7009</offset><text>Histograms for particle size, set with apertures for white blood cells 		  (24&#8211;300 &#956; m/100 &#956; l), red blood cells (30&#8211;250 &#956; m/100 &#956; l) 		  and platelets (2&#8211;20&#956; m/100 &#956; l), did not show any alteration of the 		  histogram suggesting particle size &gt; 2 &#956; m in diameter. At no point did 		  any of the samples, control or study, fail to pass a 2 &#956; m aperture. Upon 		  review of the white blood cells, red blood cells, and platelet histograms 		  generated by the hematology analyzer, we could not identify any foreign 		  particles in the animal blood. We could not rule out the presence of particles 		  in very low concentrations, ie &#8804; 3 &#215; 103 particles/&#956; 		  l, which would be the acceptable background count on this instrument. No 		  particles from various samples could be identified as examined by phase 		  microscope, light microscope and Wright stain smears in both control and study 		  groups.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>7929</offset><text>Mean heart rate, respirations, and temperature were 134 &#177; 8 		  beat/min, 22 &#177; 4 breath/min, and 38 &#177; 0.7&#176;C, respectively.</text></passage><passage><infon key="file">cc-3-1-051-1.jpg</infon><infon key="id">F1</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>8056</offset><text>Peripheral multilumen catheter cutdown sites and proximal venous
				blood sampling sites.</text></passage><passage><infon key="file">T1.xml</infon><infon key="id">T1</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>8147</offset><text>The total parenteral nutrition solution</text></passage><passage><infon key="file">T1.xml</infon><infon key="id">T1</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version="1.0" encoding="UTF-8"?&gt;
&lt;table frame="hsides" rules="groups"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align="left"&gt;Amino acids&lt;/td&gt;&lt;td align="center"&gt;2.5%&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Dextrose&lt;/td&gt;&lt;td align="center"&gt;10%&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Intralipids&lt;/td&gt;&lt;td align="center"&gt;1.25%&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;NaCl&lt;/td&gt;&lt;td align="center"&gt;30 mEq&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;KCl&lt;/td&gt;&lt;td align="center"&gt;10 mEq&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Ca gluconate&lt;/td&gt;&lt;td align="center"&gt;1000 mEq&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;K&lt;sup&gt;2&lt;/sup&gt;HPO&lt;sub&gt;4&lt;/sub&gt;&lt;/td&gt;&lt;td align="center"&gt;5 mEq&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;MVI-12&lt;/td&gt;&lt;td align="center"&gt;1 ampule&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;MgSO&lt;sub&gt;4&lt;/sub&gt;&lt;/td&gt;&lt;td align="center"&gt;200 mg&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Trace elements&lt;/td&gt;&lt;td align="center"&gt;5 ml&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Total volume&lt;/td&gt;&lt;td align="center"&gt;500 ml&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>8187</offset><text>Amino acids	2.5%	 	Dextrose	10%	 	Intralipids	1.25%	 	NaCl	30 mEq	 	KCl	10 mEq	 	Ca gluconate	1000 mEq	 	K2HPO4	5 mEq	 	MVI-12	1 ampule	 	MgSO4	200 mg	 	Trace elements	5 ml	 	Total volume	500 ml	 	</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">title_1</infon><offset>8385</offset><text>Discussion</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>8396</offset><text>Central venous catheters in the pediatric population, and especially 		  in the pediatric intensive care setting, are commonly used for the 		  administration of intravenous fluids, drugs, chemotherapeutic agents, inotropic 		  agents, and hyperalimentation. Access to the intravascular space includes the 		  femoral, subclavian, and internal jugular veins. The procedure is not without 		  complications; these include bleeding, venous thrombosis, vessel perforation, 		  sepsis, dysrhythmias, and catheter dislodgment or leakage, among others. 		  Complications are relatively common in the pediatric and neonatal population 		  with a reported incidence of 11.6% and 53% in two separate studies. Leakage and extravasation of drugs 		  and fluids can have major consequences for the patient. Local edema, 		  inflammation, infection, and necrosis are the most serious complications of 		  fluid extravasation and may lead to tissue loss requiring reconstructive 		  surgery and, in some cases, may cause loss of extremities. Dislodgment of the 		  catheter can also lead to the death of the patient.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>9499</offset><text>A plausible reason for this high incidence of fluid extravasation may 		  be the distance between the proximal and distal ports in commercially available 		  multilumen pediatric catheters. While the distal lumen may lie within the 		  intravascular space, the proximal lumen may be close to the site of entry of 		  the vein or even outside the vein. This increases the possibility of 		  extravasation if the catheter is accidentally dislodged or is not sutured 		  properly.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>9977</offset><text>The new triple-lumen catheter, with decreased port to port distances 		  and shorter catheter length compared to commercially available catheters, was 		  developed for use in the smallest possible patients. The shorter port to port 		  distance and catheter length may help to minimize the chance that one of the 		  lumens might be positioned improperly, resulting in the potential for 		  extravascular fluid infusion or catheter dislodgment.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>10423</offset><text>Our findings are consistent with a previous study showing that the simultaneous infusion of phenytoin and TPN 		  solutions did not cause the precipitation of particles large enough to be of 		  clinical significance.</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">title_1</infon><offset>10641</offset><text>Conclusion</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">paragraph</infon><offset>10652</offset><text>Our study examined the use of a triple-lumen catheter with 0.4 cm port distance, 1.3 cm ports between distal and medial ports, 5 cm overall length, and modified catheter for in vivo administration of incompatible solutions, including phenytoin and TPN, using redesigned catheters. We used previously published methodology to investigate the effects of administering drugs administered through specialized catheter models, but not those of another individual designed for intravenous administration.</text></passage><passage><infon key="fpage">16</infon><infon key="name_0">surname:Recker;given-names:DH</infon><infon key="name_1">surname:Metzler;given-names:DJ</infon><infon key="section_type">REF</infon><infon key="source">Crit Care Nurse</infon><infon key="type">ref</infon><infon key="volume">4</infon><infon key="year">1984</infon><offset>11536</offset><text>Use of the multilumen catheter.</text></passage><passage><infon key="fpage">1164</infon><infon key="lpage">1166</infon><infon key="name_0">surname:Jaimovich;given-names:DG</infon><infon key="name_1">surname:Rose;given-names:WW</infon><infon key="pub-id_pmid">2119936</infon><infon key="section_type">REF</infon><infon key="source">Crit Care Med</infon><infon key="type">ref</infon><infon key="volume">18</infon><infon key="year">1990</infon><offset>11568</offset><text>In vivo evaluation of simultaneous administration of 			 incompatible drugs via a double-lumen peripheral catheter.</text></passage><passage><infon key="fpage">271</infon><infon key="lpage">277</infon><infon key="name_0">surname:Collins;given-names:JL</infon><infon key="name_1">surname:Lutz;given-names:RJ</infon><infon key="pub-id_pmid">1903369</infon><infon key="section_type">REF</infon><infon key="source">Heart Lung</infon><infon key="type">ref</infon><infon key="volume">20</infon><infon key="year">1991</infon><offset>11684</offset><text>In vitro study of simultaneous infusion of incompatible 			 drugs in multilumen catheters.</text></passage><passage><infon key="fpage">129</infon><infon key="lpage">139</infon><infon key="name_0">surname:Strauss;given-names:RH</infon><infon key="section_type">REF</infon><infon key="source">Pediatric Critical Care.</infon><infon key="type">ref</infon><infon key="year">Edited by Fuhrman BP, Zimmerman
			 JJ. St Louis: Mosby Year-Book Inc;1992</infon><offset>11775</offset><text>Pediatric vascular access.</text></passage><passage><infon key="fpage">1346</infon><infon key="lpage">1348</infon><infon key="name_0">surname:Krasna;given-names:IH</infon><infon key="name_1">surname:Krause;given-names:T</infon><infon key="section_type">REF</infon><infon key="source">J Ped Surg</infon><infon key="type">ref</infon><infon key="volume">26</infon><infon key="year">1991</infon><offset>11802</offset><text> Life-threatening fluid extravasation of central venous 			 catheters.</text></passage><passage><infon key="fpage">153</infon><infon key="lpage">158</infon><infon key="name_0">surname:Schiff;given-names:DE</infon><infon key="name_1">surname:Stonestreet;given-names:BS</infon><infon key="section_type">REF</infon><infon key="source">J Perinatology</infon><infon key="type">ref</infon><infon key="volume">13</infon><infon key="year">1993</infon><offset>11873</offset><text> Central venous catheters in low birth weight infants: incidence of 			 related complications.</text></passage><passage><infon key="fpage">645</infon><infon key="lpage">650</infon><infon key="name_0">surname:Goutail-Flaud;given-names:MF</infon><infon key="name_1">surname:Sfez;given-names:M</infon><infon key="name_2">surname:Berg;given-names:A</infon><infon key="section_type">REF</infon><infon key="source">J Ped Surg</infon><infon key="type">ref</infon><infon key="volume">26</infon><infon key="year">1991</infon><offset>11968</offset><text>Central venous catheterrelated complications in newborns and 			 infants: a 587-case survey.</text></passage><passage><infon key="fpage">544</infon><infon key="lpage">548</infon><infon key="name_0">surname:Hruszkewycz;given-names:V</infon><infon key="name_1">surname:Holtrop;given-names:PC</infon><infon key="name_2">surname:Batton;given-names:DG</infon><infon key="pub-id_pmid">1940277</infon><infon key="section_type">REF</infon><infon key="source">Infect Control Hosp Epidemiol</infon><infon key="type">ref</infon><infon key="volume">12</infon><infon key="year">1991</infon><offset>12061</offset><text>Complications associated with central venous catheters inserted in 			 critically ill neonates.</text></passage><passage><infon key="fpage">893</infon><infon key="lpage">896</infon><infon key="name_0">surname:Lavandosky;given-names:G</infon><infon key="name_1">surname:Gomez;given-names:R</infon><infon key="name_2">surname:Montes;given-names:J</infon><infon key="pub-id_pmid">8706473</infon><infon key="section_type">REF</infon><infon key="source">Crit Care Med</infon><infon key="type">ref</infon><infon key="volume">24</infon><infon key="year">1996</infon><offset>12157</offset><text>Potentially lethal misplacement of femoral central venous 			 catheters.</text></passage></document></collection>